Trial Profile
A safety, tolerability, pharmacokinetics, and pharmacodynamic multiple ascending dose study of VTP-27999 in salt-dependent healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs VTP 27999 (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Vitae Pharmaceuticals
- 03 Dec 2015 New trial record